Surendra K. Sharma

ORCID: 0000-0003-1128-1672
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Tuberculosis Research and Epidemiology
  • Mycobacterium research and diagnosis
  • Infectious Diseases and Tuberculosis
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Diagnosis and treatment of tuberculosis
  • Pneumonia and Respiratory Infections
  • Obstructive Sleep Apnea Research
  • Immune Cell Function and Interaction
  • Asthma and respiratory diseases
  • Immunodeficiency and Autoimmune Disorders
  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • Respiratory Support and Mechanisms
  • Intensive Care Unit Cognitive Disorders
  • Neuroscience of respiration and sleep
  • Diabetes Management and Research
  • Diabetes Treatment and Management
  • Immune responses and vaccinations
  • Essential Oils and Antimicrobial Activity
  • IL-33, ST2, and ILC Pathways
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Infectious Diseases and Mycology
  • Phytochemistry and Biological Activities

Jamia Hamdard
1996-2024

Bihar Agricultural University
2024

All India Institute of Medical Sciences
2013-2023

Datta Meghe Institute of Medical Sciences
2017-2023

Institute of Molecular Medicine
2017-2023

Jawaharlal Nehru Medical College
2017-2022

National Institute of Ayurveda
2022

Bangalore Diabetes Centre
2020

Guru Jambheshwar University of Science and Technology
2008-2018

Delhi Pharmaceutical Science and Research University
2018

Obstructive sleep apnea is associated with an increased prevalence of the metabolic syndrome and its components. It unclear whether treatment obstructive continuous positive airway pressure (CPAP) would modify these outcomes.In our double-blind, placebo-controlled trial, we randomly assigned patients to undergo 3 months therapeutic CPAP followed by sham CPAP, or vice versa, a washout period 1 month in between. Before after each intervention, obtained measurements anthropometric variables,...

10.1056/nejmoa1103944 article EN New England Journal of Medicine 2011-12-14

Introduction: Tuberculosis (TB) is a major cause of morbidity and mortality globally. Extrapulmonary TB (EPTB) constitutes about 15%-20% all patients, but accounts for 50% among HIV-coinfected. Confirmation microbial diagnosis EPTB usually challenging.Areas covered: Availability newer imaging modalities like 18FDG-PET-CT PET-MRI has facilitated precise anatomical localization the lesions mapping extent EPTB. The use image- endoscopy-guided invasive diagnostic methods made procurement...

10.1080/17476348.2021.1927718 article EN Expert Review of Respiratory Medicine 2021-05-09

Xpert MTB/RIF is a novel automated molecular diagnostic recently endorsed by the World Health Organization. However, performance-related data from high HIV prevalence settings are limited.The impact of sample-related factors on performance and significance MTB/RIF-positive culture-negative discordance remain unclear.Xpert was evaluated using single archived spot-sputum samples 496 South African patients with suspected TB. Mycobacterium tuberculosis culture positivity phenotypic resistance to...

10.1164/rccm.201101-0056oc article EN American Journal of Respiratory and Critical Care Medicine 2011-04-15

Extrapulmonary tuberculosis (EPTB) is frequently a diagnostic and therapeutic challenge. It common opportunistic infection in people living with HIV/AIDS other immunocompromised states such as diabetes mellitus malnutrition. There paucity of data from clinical trials EPTB most the information regarding diagnosis management extrapolated pulmonary TB. Further, there are no formal national or international guidelines on EPTB. To address these concerns, Indian were developed under auspices...

10.4103/ijmr.ijmr_1950_16 article EN The Indian Journal of Medical Research 2017-04-01

Interstitial lung disease (ILD) is a heterogeneous group of acute and chronic inflammatory fibrotic diseases. Existing ILD registries have had variable findings. Little known about the clinical profile ILDs in India.To characterize new-onset India by creating prospective using multidisciplinary discussion (MDD) to validate diagnoses.Adult patients Indian origin living with (27 centers, 19 cities, March 2012-June 2015) without malignancy or infection were included. All connective tissue (CTD)...

10.1164/rccm.201607-1484oc article EN American Journal of Respiratory and Critical Care Medicine 2016-09-29
Shilpi Aggarwal Sapna Negi Pankaj Jha Prashant Singh Tsering Stobdan and 95 more M. A. Qadar Pasha Saurabh Ghosh Anurag Agrawal Bhavana Prasher Mitali Mukerji Samir K. Brahmachari Partha P. Majumder Mitali Mukerji Saman Habib Debasis Dash Kunal Ray S. Bahl Lalji Singh Abhay Sharma Susanta Roychoudhury Giriraj R. Chandak Kumarasamy Thangaraj Devendra Parmar Shiladitya Sengupta Dwaipayan Bharadwaj Srikanta Kumar Rath J. Singh Ganga Nath Jha Komal Virdi Vadlamudi Raghavendra Rao Swapnil Sinha Ashish Kumar Singh Amit Mitra Shrawan K. Mishra Qadar Pasha Sridhar Sivasubbu Rajesh Pandey Aradhita Baral P. K. Singh Abhay Sharma Jitender Kumar Tsering Stobdan Yasha Bhasin C Chauhan Ashik Hussain Elayanambi Sundaramoorthy SP Singh Arun Bandyopadhyay Kamal Dasgupta A. K. Reddy Charles J. Spurgeon Mohammed M. Idris Vinay K. Khanna Uma Dhawan M. Anand Ravi Shankar Ram Suresh Bharti Mahendra Pratap Singh Ashish Pratap Singh Anwar Jamal Khan Parag P. Shah AB Pant Rupinder Kaur Kamlesh Bisht Satyam Kumar Agrawal Manickam Chidambaram Elizabeth Wilson Antony Thangadurai Pankaj Jha Mahua Maulik Namrata Kumar Makhija Abdur Rahim Surendra K. Sharma Rupali Chopra Palak Rana Manickam Chidambaram Arindam Maitra Ruchi Chawla Shivani Soni Preeti Khurana M. Nadeem Khan Sushanta Das Sutar Amit Tuteja K. Narayansamy Rammohan Shukla Satya Prakash Swapna Mahurkar‐Joshi K. Radha Mani J. Hemavathi S. Bhaskar Pankaj Khanna G. S. Ramalakshmi S. M. Tripathi Neelam Thakur B. Ghosh Ritushree Kukreti Taruna Madan Rajesh Verma G. Sudheer Anubha Mahajan

It is being realized that identification of subgroups within normal controls corresponding to contrasting disease susceptibility likely lead more effective predictive marker discovery. We have previously used the Ayurvedic concept Prakriti , which relates phenotypic differences in individuals, including response external environment as well diseases, explore molecular between three types: Vata, Pitta, and Kapha . EGLN1 was one among 251 differentially expressed genes types. In present study,...

10.1073/pnas.1006108107 article EN Proceedings of the National Academy of Sciences 2010-10-18

Pulmonary tuberculosis still remains a major communicable disease worldwide. In 2013, 9 million people developed TB and 1.5 died from the disease. India constitutes 24% of total burden. Early detection cases is key to successful treatment reduction transmission. Xpert MTB/RIF, an automated cartridge-based molecular technique detects Mycobacterium rifampicin resistance within two hours has been endorsed by WHO for rapid diagnosis TB. Our study first with large sample size evaluate performance...

10.1371/journal.pone.0141011 article EN cc-by PLoS ONE 2015-10-23

Background The accurate diagnosis of TB in HIV-infected patients, particularly with advanced immunosuppression, is difficult. Recent studies indicate that a lipoarabinomannan (LAM) assay (Clearview-TB®-ELISA) may have some utility for the patients; however, precise subgroup benefit from this technology requires clarification. LAM sputum samples has, hitherto, not been evaluated. Methods was measured and urine obtained 500 consecutively recruited ambulant suspected TB, 2 primary care clinics...

10.1371/journal.pone.0009848 article EN cc-by PLoS ONE 2010-03-23

Background There are currently two tests for diagnosing latent tuberculosis infection (LTBI); TST and IGRA. However, it is still unclear that which one of these performs better in high TB-burden settings. Methods 1511 household contacts pulmonary TB patients were enrolled to compare the performance IGRA LTBI. At baseline all participant underwent testing [QuantiFERON-TB® Gold In-tube (QFT-GIT) assay] [2 tuberculin unit (TU), purified protein derivative (PPD), RT23, Staten Serum Institute...

10.1371/journal.pone.0169539 article EN cc-by PLoS ONE 2017-01-06

Prolonged treatment of tuberculosis (TB) often leads to poor compliance, default and relapse, converting primary TB patients into category II (Cat IITB) cases, many whom may convert multi-drug resistant (MDR-TB). We have evaluated the immunotherapeutic potential Mycobacterium indicus pranii (MIP) as an adjunct Anti-Tubercular Treatment (ATT) in Cat pulmonary (PTB) a prospective, randomized, double blind, placebo controlled, multicentric clinical trial. 890 sputum smear positive PTB were...

10.1038/s41598-017-03514-1 article EN cc-by Scientific Reports 2017-06-07

The inadequacy of effector T-cell response in containment tubercle bacilli is believed to result the development disseminated forms tuberculosis (TB), such as miliary (MTB). Regulatory T cells (Treg) plausibly play a critical role immunopathogenesis TB by suppression immune against Mycobacterium at pathologic site(s). To understand Treg tuberculosis, we studied frequency and function derived from local disease site specimens (LDSS) patients with pleural effusion MTB clinical models contained...

10.1164/rccm.200804-529oc article EN American Journal of Respiratory and Critical Care Medicine 2009-02-27

10.1016/s0012-3692(15)50981-1 article EN CHEST Journal 2006-07-01

Background The objectives of the study were to compare performance line probe assay (GenoType MTBDRplus) with solid culture method for an early diagnosis multidrug resistant tuberculosis (MDR-TB), and mutation patterns associated rpoB, katG inhA genes at a tertiary care centre in north India. Methods In this cross-sectional study, 269 previously treated sputum-smear acid-fast bacilli (AFB) positive MDR-TB suspects enrolled from January September 2012 All India Institute Medical Sciences...

10.1371/journal.pone.0072036 article EN cc-by PLoS ONE 2013-09-05
Coming Soon ...